Product Images Glyburide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Glyburide NDC 71209-009 by Cadila Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

container-label-1000s-count-1-25mg.jpg - container label 1000s count 1 25mg

container-label-1000s-count-1-25mg.jpg - container label 1000s count 1 25mg

This appears to be a label for a medication, specifically GlyBURIDE Tablets, USP. The label includes dosage instructions, storage information, and safety warnings. It is manufactured by Cadila Pharmaceuticals Ltd in India.*

container-label-1000s-count-2-5mg.jpg - container label 1000s count 2 5mg

container-label-1000s-count-2-5mg.jpg - container label 1000s count 2 5mg

This appears to be a product description for GlyBURIDE tablets, USP manufactured by Cadila Pharmaceuticals LTD in India. The tablets are dispensed in 25 g quantities and have a controlled room temperature range between 15-30 degrees Celsius. The tablets should be kept away from children and manufactured according to the standards of the US Pharmacopeia.*

container-label-1000s-count-5mg.jpg - container label 1000s count 5mg

container-label-1000s-count-5mg.jpg - container label 1000s count 5mg

This appears to be a description of a medication called GlyBURIDE in tablet form, with a strength of 5mg per tablet. The recommended dosage may vary based on factors such as age and medical condition. There are also warnings to keep the medication out of reach of children. The manufacturer is listed as CADILA PHARMACEUTICALS LTD, located in Gujarat, India. Additionally, there is a reference to a medication number and a lot number.*

container-label-100s-count-1-25mg.jpg - container label 100s count 1 25mg

container-label-100s-count-1-25mg.jpg - container label 100s count 1 25mg

container-label-100s-count-2-5mg.jpg - container label 100s count 2 5mg

container-label-100s-count-2-5mg.jpg - container label 100s count 2 5mg

container-label-100s-count-5mg.jpg - container label 100s count 5mg

container-label-100s-count-5mg.jpg - container label 100s count 5mg

container label 500s count 2 5mg

container label 500s count 2 5mg

Each tablet contains 2.5 mg glyburide, and it is recommended to store it at 20-25°C with directions provided in accompanying literature. The tablet should be dispensed in a tight, light-resistant container with child-resistant closure. It is crucial to keep the medication out of the reach of children. The manufacturer is Cadila Pharmaceuticals Ltd, located in Gujarat State, India, and their manufacturing license number is G/1500. The tablets are marked with Noc 71208-010-10 and the name "GlyBURIDE". Actual size specifications and label color information are also provided.*

container label 500s count 5mg

container label 500s count 5mg

Each tablet of GlyBURIDE contains 5 g of USP. The recommended storage temperature is between 20°C to 25°C (66°F to 77°F) with limited excursions allowed. Keep the medication in a secure and light-resistant container with a child-resistant closure. It is essential to keep all medications out of children's reach. The manufacturer is Cadila Pharmaceuticals Ltd, with Mfg. Lic. No.: G/1500, located in Gujarat State, India. The tablet is used as a diabetes medication, and the usual dosage can be found in the accompanying literature. The label dimensions are 120 x 45 mm.*

glyburide-fig-1 - glyburide fig 1

glyburide-fig-1 - glyburide fig 1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.